Lupin is an innovation led Transnational Pharmaceutical Company producing developing and marketing a wide range of branded & generic formulations biotechnology products and active pharmaceutical ...
Lupin exceeded profit expectations in the second quarter, reporting a 74% surge in profits, reaching ₹8.53 billion. This growth was fueled by robust demand for their respiratory and diabetes ...